The Centers for Medicare & Medicaid Services recently issued a memo clarifying its ligature risk policy, which pertains to environmental safeguards for patients at risk of harm to self or others. The agency expects to release comprehensive guidance for state survey agencies and accrediting organizations in the next six months. Meanwhile, the accrediting body or state agency has authority to determine the level of citation for ligature deficiencies based on its expert opinion, CMS said. According to the clarifying memo, the focus for a ligature “resistant” or ligature “free” environment is primarily aimed at psychiatric hospitals and units, and does not apply to non-psychiatric units of acute care hospitals.

Headline
The Centers for Disease Control and Prevention July 14 released an advisory on the growing cyclosporiasis cases across the U.S. The advisory said that the…
Headline
The Centers for Disease Control and Prevention has reported 843 cases of cyclosporiasis across 31 states, with 86 people hospitalized. State health departments…
Headline
The Food and Drug Administration has issued an early alert for specific lots of BD ChloraPrep Applicators by Medline because of a potential breach of sterility…
Headline
The Food and Drug Administration has identified a Class I recall of North American Rescue first aid kits containing TRUE METRIX Blood Glucose Monitoring…
Headline
Angela Hewlett, M.D., professor of infectious diseases at the University of Nebraska Medical Center and medical director of the Nebraska Biocontainment Unit,…
Headline
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of…